Insurer record · Medicare Advantage · 32 contracts · Medicaid in 9 states

Humana

5.8%

of MA prior-authorization requests denied in 2024 — among the lowest of major insurers

Dataset: Prior-authorization denials · Medicare Advantage

Complete reports found See the public-record check →

From the payer’s own CY2025 posting

What Humana disclosed

MeasureWhat the insurer reportedNote
Standard requests, contract H4461280,178
Denied6.17%17,287 denials
Denials appealed4672.7% — 97% never challenged
Appeals won by patients67.02%313 of 467
Expedited requests denied9.36%vs 6.17% standard
Mean decision time1 day standard · 5 hours expedited
Reports posted32 MA contracts + 9 state Medicaid
Source · Humana contract H4461 prior-authorization metrics, plan year 2025
Published
2026
Capture note
Direct static PDF; captured Jul. 9, 2026.
Public lineage
Original source linked below. A public immutable archive and provenance ID are not yet published.
Open original source ↗
Appeal drafting · free to use

Denied by Humana? Build a fact-specific draft.

Start with the facts in your notice. The builder adds public context only when it matches Medicare Advantage prior authorization, and labels that context so it is not confused with evidence about your individual request.

Write my appeal letter

The block below is for Medicare Advantage prior-authorization appeals only.

I ask that my Medicare Advantage prior-authorization appeal be reviewed carefully. I include the following public figures as background only; they do not describe my individual request and do not, by themselves, show that this denial was incorrect: - KFF's analysis of insurer-reported CMS data found that 80.7% of appealed Medicare Advantage prior-authorization denials were overturned in 2024. CMS does not audit these insurer submissions (https://www.kff.org/medicare/medicare-advantage-insurers-made-nearly-53-million-prior-authorization-determinations-in-2024/). - Humana’s 2025 posting for Medicare contract H4461 reports that 313 of 467 appealed prior-authorization denials, or 67.02%, were decided in the member’s favor. (https://assets.humana.com/is/content/humana/Humana_H4461_Prior_Auth_Metrics_PlanYear2025pdf). Please reconsider my individual request on its facts, provide the specific criteria used, and identify the credentials of any clinician who reviewed it.

On the record

The Senate flagged its long-term-care denials.

The Senate PSI report found Humana's denial rate for long-term acute care hospital stays grew 54% between 2020 and 2022, reaching more than sixteen times its overall denial rate.

Source · U.S. Senate Permanent Subcommittee on Investigations, majority staff report
Published
Oct. 17, 2024
Public lineage
Original source linked below. A public immutable archive and provenance ID are not yet published.
Open original source ↗

See how these figures are collected, what they can and cannot tell you, and how to request a correction on the methodology page. Compare payers on the rankings page.